Special Issue "Photodynamic Therapy: Rising Star in Pharmaceutical Applications"

A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Clinical Pharmaceutics".

Deadline for manuscript submissions: 20 October 2023 | Viewed by 194

Special Issue Editors

Department of Pharmaceutics and Biopharmaceutics, University of Marburg, Robert-Koch-Str. 4, 35037 Marburg, Germany
Interests: nanoscale drug delivery systems; photodynamic therapy; liposomes; gene therapy
Special Issues, Collections and Topics in MDPI journals
Department of Pharmaceutics and Biopharmaceutics, University of Marburg, Robert-Koch-Str. 4, 35037 Marburg, Germany
Interests: photodynamic therapy; antimicrobial therapy; nanofibers; polymeric nanoparticles
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Ancient Egyptians, Greeks, and Romans used the positive effects of light against various diseases even thousands of years ago. Nevertheless, it took humanity until the late 19th century and early 20th century to overcome the preconception of phototherapy being an outgrowth of naturism. Nobel prize winner Niels Ryberg Finsen was one of the first to turn the spotlight on phototherapy and photodynamic therapy. Later, known researchers, like Downes and Blunt, Oscar Raab, and Hermann von Tappeiner, followed this path and made significant contributions to this field.

In this follow-up special issue of https://www.mdpi.com/journal/pharmaceutics/special_issues/Honor_Michael, we invite all researchers to contribute to our volume II and, in this way, accelerate the inclusion of photodynamic therapy in clinical practice guidelines.

Prof. Dr. Udo Bakowsky
Dr. Eduard Preis
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • all applications of PDT, e.g.,
    • PDT in tumor therapy
    • PDT in antimicrobial therapy (including biofilms and chronic wounds)
    • PDT in antiviral therapy (including COVID-19)
  • PDT in combination with other types of therapy, e.g.,
    • classical chemotherapy
    • antibiotics
    • stem-cell therapy
    • radiation therapy
    • ultrasound applications
    • photothermal therapy (PTT)
  • new photosensitizers and their effects
  • clinical applications of PDT
  • new carrier systems for PDT and their physicochemical characterization, e.g.,
    • liposomes
    • micelles
    • nanoparticles
    • fibers
    • nanorods

Related Special Issue

Published Papers

This special issue is now open for submission.
Back to TopTop